02-Nov-2026 | Zion Market Research
According to the report, the global point of care diagnostics market size was valued at approximately USD 17.29 billion in 2024 and is expected to reach around USD 37.51 billion by the end of 2034, expanding at a CAGR of approximately 8.2% from 2025 to 2034.

High-Quality & Cost-Effective Medical Solutions And Technological Advancement To Power Point Of Care Diagnostics Market In Near Future
As per analysts at Zion Market Research, the point of care diagnostics market is likely to see lucrative development in the years to come. The point of care diagnostics market is mainly powered by high-quality & cost-effective medical solutions and technological advancement. In addition to this, rising occurrence of target diseases paired with the increment in the elderly user base that is more defenseless to diseases are likely to foster the demand for point of care diagnostics market significantly in the coming years. On the other hand, the presence of time-consuming & stringent confusing regulatory structure and high price of procedure are likely to hinder the growth of point of care diagnostics market in the years to come.
Nevertheless, health care decentralization and rising demand from up-and-coming nations might unlock up new growth opportunities in the years to come. Moreover, new launches by market players is also set to boost point of care diagnostics market. For example, in June 2017, Roche rolled out new mobile app for tablets to additionally enhance the performance for POC (point-of-care) coordinators.

| Report Attributes | Report Details |
|---|---|
| Report Name | Point of Care Diagnostics Market |
| Market Size in 2024 | USD 17.29 Billion |
| Market Forecast in 2034 | USD 37.51 Billion |
| Growth Rate | CAGR of 8.2% |
| Number of Pages | 260 |
| Key Companies Covered | Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, Chembio Diagnostics, Quidel Diagnostics, Trinity Biotech, EKF Diagnostics, Fluxergy, and others. |
| Segments Covered | By Product, By Prescription Mode, By End User, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
| Base Year | 2024 |
| Historical Year | 2020 - 2023 |
| Forecast Year | 2025 - 2034 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The point of care diagnostics market is segmented based on product, prescription mode, end user, and region.
Based on Product Segment, The point of care diagnostics market is divided into glucose monitoring kits, cardiometabolic monitoring kits, infectious diseases testing kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and others. Glucose monitoring kits lead due to the high burden of diabetes requiring frequent testing, while infectious disease kits grow rapidly on the need for rapid pathogen detection, together supporting overall market expansion.
Based on Prescription Mode Segment, The point of care diagnostics market is divided into prescription-based testing kits and over-the-counter testing kits. Prescription-based kits dominate clinical settings that require professional oversight, while over-the-counter options expand home and consumer access, broadening market reach and innovation.
Based on End User Segment, The point of care diagnostics market is divided into hospitals, clinics, and ambulatory care settings. Hospitals and clinics drive the majority of demand through the need for rapid results in acute and chronic care, while ambulatory settings contribute additional volume closer to patients.
North America to dominate the global market
North America continues to lead through advanced healthcare infrastructure, high adoption of rapid diagnostics, rising chronic disease prevalence, strong spending power, and supportive hospital and public initiatives that collectively set standards and drive sustained market growth, innovation, and expansion.
Browse the full "Point of Care Diagnostics Market By Product (Glucose Monitoring Kits, Cardiometabolic Monitoring Kits, Infectious Diseases Testing Kits, Coagulation Monitoring Kits, Pregnancy and Fertility Testing Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Others), By Prescription Mode (Prescription-based Testing Kits, Over-the-counter (OTC) Testing Kits), By End User (Hospitals, Clinics, Ambulatory Care Settings), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034" report at https://www.zionmarketresearch.com/report/point-of-care-diagnostics-market
Key players with a major share in the global point of care diagnostics market include;
The global point of care diagnostics market is segmented as follows:
By Product
By Prescription Mode
By End User
By Region
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
US OFFICE NO: +1 (302) 444-0166
USA/Canada Toll-Free No: 1-855-465-4651
APAC: +91 7768 006 007, +91 7768 006 008
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com